Drug Trial Radar · NCT01994889
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
Last checked: Nov 20, 2026Latest source record: Apr 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
441
Actual
Start
Dec 9, 2013
Primary completion
Feb 7, 2018
Study completion Feb 7, 2018
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Nov 26, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 study will investigate the efficacy, safety and tolerability of an oral daily dose of 20 mg or 80 mg tafamidis meglumine capsules compared to placebo in subjects with either transthyretin genetic variants or wild-type transthyretin resulting in amyloid cardiomyopathy.
Conditions
- Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions
TafamidisDrug
Tafamidis 20 mg in soft gel capsules administered once a day for 30 months
TafamidisDrug
Tafamidis 80 mg in soft gel capsules administered once a day for 30 months
PlaceboDrug
Placebo in soft gel capsules administered once a day for 30 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hierarchical Combination of All-Cause Mortality and Frequency of Cardiovascular-Related HospitalizationsTime frame: Baseline up to Month 30
Locations
80 sites in 13 countries. Site status is shown where the registry gives one.
The Kirklin Clinic
Birmingham, Alabama
UAB Hospital Department of Pharmacy IDS
Birmingham, Alabama
University Hospital, University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Arizona - Mayo Clinic Speciality Building
Phoenix, Arizona
Mayo Clinic Hospital
Phoenix, Arizona
Mayo Clinic Arizona - Mayo Clinic Building
Scottsdale, Arizona
UCSD Clinical and Translational Research Institute, Investigational Drug Service
La Jolla, California
Altman Clinical Translational Research institute
La Jolla, California
Altman Clinical Translational Research Institute
La Jolla, California
UCSD Sulpizio Cardiovascular Center
La Jolla, California
Cedars-Sinai Medical Center, Investigational Drug Pharmacy Services
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Cedars-Sinai Medical Care Foundation
Los Angeles, California
UCSF Cardiovascular Care and Prevention Center
San Francisco, California
Stanford University Hospital and Clinics
Stanford, California
UM Sylvester at Deerfield Beach
Deerfield Beach, Florida
University of Miami Hospital & Clinics
Miami, Florida
Northwestern Medical Group
Chicago, Illinois
Northwestern Memorial Hospital
Chicago, Illinois
Advocate Christ Medical Centre
Oak Lawn, Illinois
Ochsner Medical Center
New Orleans, Louisiana
University of Maryland, School of Medicine
Baltimore, Maryland
Johns Hopkins University
Baltimore, Maryland
The Johns Hopkins Hospital IDS Pharmacy
Baltimore, Maryland
Boston Medical Center - Cardiovascular Center, Outpatient Clinic
Boston, Massachusetts
Boston Medical Center Investigational Pharmacy Services
Boston, Massachusetts
Boston Medical Center
Boston, Massachusetts
Boston University Medical Center General Clinical Research Unit
Boston, Massachusetts
Michigan Medicine,University of Michigan
Ann Arbor, Michigan
Mayo Clinic Pharmacy Research Supp
Rochester, Minnesota
Mayo Clinic
Rochester, Minnesota
Newark Beth Israel Medical Center
Newark, New Jersey
New York University Hospitals
New York, New York
Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital
New York, New York
Mount Sinai Doctors Faculty Practice
New York, New York
The Mount Sinai Hospital Department of Pharmacy
New York, New York
Columbia University Medical Center Research Pharmacy
New York, New York
Columbia University Medical Center/Clinical Cardiovascular Research Laboratory for the Elderly
New York, New York
Duke University Health System
Durham, North Carolina
Cleveland Clinic
Cleveland, Ohio
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.